Cheryl Renee Blanchard Ph.D.
Net Worth

Last updated:

What is Cheryl Renee Blanchard Ph.D. net worth?

The estimated net worth of Dr. Cheryl Renee Blanchard Ph.D. is at least $5,982,578 as of 11 Mar 2024. He owns shares worth $482,578 as insider and has received compensation worth at least $5,500,000 in Anika Therapeutics, Inc..

What is the salary of Cheryl Renee Blanchard Ph.D.?

Dr. Cheryl Renee Blanchard Ph.D. salary is $1,100,000 per year as Pres, Chief Executive Officer & Director in Anika Therapeutics, Inc..

How old is Cheryl Renee Blanchard Ph.D.?

Dr. Cheryl Renee Blanchard Ph.D. is 61 years old, born in 1964.

What stocks does Cheryl Renee Blanchard Ph.D. currently own?

As insider, Dr. Cheryl Renee Blanchard Ph.D. owns shares in one company:

Company Title Shares Price per share Total value
Anika Therapeutics, Inc. (ANIK) Pres, Chief Executive Officer & Director 56,179 $8.59 $482,578

What does Anika Therapeutics, Inc. do?

Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform. Its OA pain management product family consists of Monovisc, Orthovisc, Cingal, and Hyvisc that are indicated to provide pain relief from osteoarthritis conditions; and joint preservation and restoration product family comprise a portfolio of approximately 150 bone preserving joint technology products, a line of sports medicine soft tissue repair solutions, and orthopedic regenerative solutions products. The company's non-orthopedic product family include HA-based products for non-orthopedic applications, including adhesion barrier products, advanced wound care products, ophthalmic products, and ear, nose, and throat products. Anika Therapeutics, Inc. was founded in 1983 and is headquartered in Bedford, Massachusetts.

ANIK logo
ANIK
Anika Therapeutics, Inc.
$8.59

Cheryl Renee Blanchard Ph.D. insider trading

Anika Therapeutics, Inc.

Transaction Date Security Shares Price per share Total value Source
Option
Restricted Stock Unit 20,001 N/A N/A
Option
Common Stock 30,059 N/A N/A
Option
Restricted Stock Unit 30,059 N/A N/A
Option
Common Stock 20,001 N/A N/A
Option
Common Stock 14,420 N/A N/A
Option
Restricted Stock Unit 14,420 N/A N/A
Option
Restricted Stock Unit 24,575 N/A N/A
Option
Common Stock 24,575 N/A N/A
Option
Common Stock 30,060 N/A N/A
Option
Restricted Stock Unit 30,060 N/A N/A
Option
Common Stock 14,419 N/A N/A
Option
Restricted Stock Unit 14,419 N/A N/A
Option
Restricted Stock Unit 24,576 N/A N/A
Option
Common Stock 24,576 N/A N/A
Purchase
Common Stock 3,813 $25.81 $98,429
Purchase
Common Stock 4,287 $25.36 $108,714
Option
Restricted Stock Unit 14,420 N/A N/A
Option
Common Stock 14,420 N/A N/A
Option
Stock Option (Right to Buy) 2,994 N/A N/A
Option
Common Stock 2,994 N/A N/A
Option
Common Stock 24,575 N/A N/A
Option
Restricted Stock Unit 24,575 N/A N/A
Option
Common Stock 4,231 N/A N/A

Anika Therapeutics key executives

Anika Therapeutics, Inc. executives and other stock owners filed with the SEC: